Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro
- PMID: 1374791
- DOI: 10.1002/jmv.1890360204
Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro
Abstract
Multiple mutations in the reverse transcriptase (RT) gene were observed in a drug-resistant isolate of human immunodeficiency virus type 1 (HIV1) from an individual having prolonged (greater than 2 years) zidovudine (AZT) therapy. The virus replicated in PBMC's in the presence of very high concentrations of AZT (125 microM). Drug-sensitive strains were curtailed by 0.01 microM AZT. Eleven defined mutations were observed as compared with published sequences of RT for eight strains of HIV1. Eight of these mutations were found in the domain involved in nucleotide recognition and enzyme function. Only one of the mutations, giving a Thr--Tyr change at amino acid 215, matched those previously ascribed (67, 70, 215, and 219) to the generation of high-level resistance to AZT. Therefore additional amino acid changes may have significance in the emergence of super-resistant viruses.
Similar articles
-
Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.J Gen Virol. 1993 Feb;74 ( Pt 2):223-8. doi: 10.1099/0022-1317-74-2-223. J Gen Virol. 1993. PMID: 7679140
-
Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.J Clin Microbiol. 1995 Feb;33(2):352-5. doi: 10.1128/jcm.33.2.352-355.1995. J Clin Microbiol. 1995. PMID: 7536214 Free PMC article.
-
[Mutations of HIV-1 RT gene isolated from patients treated with AZT].Kansenshogaku Zasshi. 1993 Mar;67(3):185-9. doi: 10.11150/kansenshogakuzasshi1970.67.185. Kansenshogaku Zasshi. 1993. PMID: 7683706 Japanese.
-
Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.J Enzyme Inhib. 1992;6(1):55-64. doi: 10.3109/14756369209041356. J Enzyme Inhib. 1992. PMID: 1285303 Review. No abstract available.
-
Molecular aspects of AZT resistance in HIV1.Res Virol. 1992 Mar-Apr;143(2):136-42. doi: 10.1016/s0923-2516(06)80099-3. Res Virol. 1992. PMID: 1594798 Review. No abstract available.
Cited by
-
Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.Antimicrob Agents Chemother. 1994 Feb;38(2):268-74. doi: 10.1128/AAC.38.2.268. Antimicrob Agents Chemother. 1994. PMID: 7514854 Free PMC article.
-
Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.Antimicrob Agents Chemother. 1993 Jun;37(6):1207-13. doi: 10.1128/AAC.37.6.1207. Antimicrob Agents Chemother. 1993. PMID: 8328771 Free PMC article. Review. No abstract available.
-
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.J Virol. 1996 Nov;70(11):8010-8. doi: 10.1128/JVI.70.11.8010-8018.1996. J Virol. 1996. PMID: 8892925 Free PMC article.
-
Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5771-5. doi: 10.1073/pnas.91.13.5771. Proc Natl Acad Sci U S A. 1994. PMID: 8016063 Free PMC article.
-
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment.Infection. 1996 Nov-Dec;24(6):419-25. doi: 10.1007/BF01713041. Infection. 1996. PMID: 9007588
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources